Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

Retinoids act as insulin sensitizers in mice

April 3, 1997

New low-dose OC cleared by FDA

April 2, 1997

First Estrophasic OC introduced in the U.S.

April 2, 1997

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Oxford Molecular/PolyMASC collaborate on development of blood growth factor

April 1, 1997

Ares-Serono and Fournier reach U.S. development and marketing agreement for HRT products

April 1, 1997

Hypoglycemic/hypolipidemic agents from Sankyo

April 1, 1997

Theratechnologies reports development strategy for second GRF analogue

March 27, 1997

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...